Fontenot Teri G. 4

What Happened

• Teri G. Fontenot, a director of AMN Healthcare Services, Inc. (AMN), was granted 8,304 restricted stock units (RSUs) on May 1, 2026.
• The grant is a derivative award (code A) with a grant price of $0.00 per RSU; no cash was paid. This is a standard equity compensation award to a director rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-01; Filing date/accession: 2026-05-04 (report covers the May 1, 2026 grant).
• Grant amount: 8,304 RSUs; grant price reported as $0.00 (award/derivative).
• Shares owned after transaction: Not specified in the provided filing summary (see full Form 4 for total holdings).
• Footnotes:
  • F1: RSUs granted under the AMN Healthcare 2025 Equity Plan; each RSU represents a contingent right to one share.
  • F2: RSUs vest on the earlier of (i) one year after the grant (May 1, 2027) or (ii) the Company’s 2027 Annual Meeting; at the director’s irrevocable election, the RSUs may settle upon separation from service.
  • F3: The RSUs have no expiration date.
• Filing timeliness: No late‑filing code was provided in the summary; the report was filed three days after the grant date (see the Form 4 for any timeliness statements).

Context

• RSU grants are a common form of director compensation and represent a contingent right to receive shares in the future rather than an immediate purchase. They do not indicate an immediate cash investment or sale by the director.
• For retail investors, awards to directors are routine and primarily reflect compensation policy; they are less directly informative about a director’s personal bullish or bearish sentiment than open‑market purchases or sales.